There has been a lot of important discussion surrounding the use of paclitaxel-coated devices to treat peripheral arterial disease. The FDA and other European regulatory agencies have issued an updated letter outlining current recommendations to health care providers who are…
Feature
Limb preservation programme key to treating BTK disease
Product
Flexor® technology helps physicians track and treat with confidence
Cook launches 140 mm drug-eluting stent
Physicians will now be able to treat longer lesions with just one stent, which is deployed via a thumbwheel delivery system.
Zilver® Vena™ 1-year results presented
One-year results of the VIVO-EU study showed treatment with the Zilver Vena Venous Self-Expanding Stent resulted in 87.9% freedom from occlusion.
Latest News
Study suggests effective treatment of symptomatic iliofemoral venous outflow obstruction1 The study, “Twelve-month end point results from the evaluation of the Zilver Vena venous stent in the treatment of symptomatic iliofemoral venous outflow obstruction (VIVO clinical study),” has shown that…
Two sales reps, a clinical support specialist, multiple project managers, and two distribution centers joined efforts to help save one critically ill baby. Physicians at Hospital Sant Joan de Déu in Barcelona were desperate for a PBS-200 (Park Blade Septostomy… 
There are surprising moments in history that can have a profound impact on the advancement of medical device technology. Flexor technology was conceived from one of these seemingly ordinary circumstances. In 1965, a casual conversation between physicians in the cafeteria… 
Physicians facing tough lesions now have a balloon angioplasty catheter in their bag that applies focal force along four longitudinal elements.1 The Advance Enforcer 35 challenges lesions with focal force. Its construction uniquely incorporates four elements that transfer focal force… 
[caption id="attachment_1431" align="alignleft" width="215"] Dr. Christopher Boyes[/caption] The following story is an example of a coordinated approach to limb salvage instituted at Sanger Heart and Vascular Institute in Charlotte, North Carolina. One of the most devastating consequences of advanced peripheral… 
Patients suffering from critical limb ischemia (CLI) are often a difficult population to treat due to the likelihood of significant comorbidities including lesions that may be extremely difficult to cross. Increasingly, physicians are crossing these difficult lesions from a tibiopedal… 
Cook Medical will sponsor three lunchtime symposia at LINC 2017 in Leipzig, Germany, from 24-26 January. World-renowned physicians will present on vascular disease states and therapies. There will also be live case demonstrations. On Tuesday, 24 January, a symposium titled… 
Three Cook Medical strategic business units—Interventional Radiology (IR), Peripheral Intervention (PI), and Aortic Intervention (AI)—have collaborated to provide innovative learning opportunities for some of the world’s leading interventional specialists at CIRSE 2016. CIRSE (Cardiovascular and Interventional Radiological Society of Europe),… 
[caption id="attachment_1284" align="alignleft" width="636"] Torcon NB® Advantage Catheters[/caption] Challenging times can often be the true test of the strength of a team. In April, our teams faced one of those challenges when we decided to recall all products with Beacon… 
Vascular and endovascular controversies take centre stage 26-29 April at the 2016 Charing Cross International Symposium in Olympia Grand, London, UK. World-class physicians will interact and debate with an expert audience to understand current topics and considerations for treating vascular… 
Cook Medical's latest addition to its broad offering of wire guides is the Roadrunner® UniGlide.® The hydrophilic UniGlide wire guide offers a familiar feel and the performance physicians expect. A durable hydrophilic coating provides trackability and pushability, and a tungsten-impregnated jacket enhances… 
Dr. Mark Meissner is a professor of surgery at the University of Washington Medical School in the United States. He specialises in vascular surgery, with particular clinical and research interests in deep vein thrombosis and chronic venous disease. He is known… 
CIRSE is an exciting opportunity for Cook to showcase our products. It’s also a great chance for CIRSE attendees to learn new techniques and procedures. This year it will be easy to find the Cook Learning Centre, because it’s inside… 
VistaSM Collaboration and Learning Program courses provide you with opportunities to enhance your endovascular skill set. Your knowledge of the treatment of peripheral arterial disease, the placement and retrieval of vena cava filters, or the embolisation of vascular malformations will… 
The proven technology of the Cook Celect® Vena Cava Filter is now improved by the addition of four platinum markers. The radiopaque markers on the Celect™ Platinum filter can help physicians verify placement accuracy immediately after filter detachment. The Celect… 
To give physicians another chance at limb salvage, Cook Medical offers products that are designed to facilitate a retrograde tibiopedal approach. These products allow you to access, target, and treat. Access • The 2.9 Fr ID Micropuncture® Pedal Introducer Access Set can… 
The angiosome concept of perfusion delineates specific vascular territories that are supplied by specific arteries. By enabling the interventionalists to target arteries according to the location of foot ulcers, the concept may help vascular interventionalists treat tissue defects caused by… 
Retracta is a detachable .035 inch coil that's fully retractable. It's easy to use and requires minimal preparation time. It's an economical choice that gives you another viable option for treating patients. The Retracta coil is based on the platinum…